John Amory

Corporate Officer/Principal at

University of Washington

59 year

Health Technology

Consumer Services

Profile

John A. Amory is a Professor at the University of Washington, where he has been working since 2011.
He previously worked as a Director at Clarus Therapeutics, Inc. and as an Independent Director at Clarus Therapeutics Holdings, Inc. from 2021 to 2022.
Amory received a graduate degree from the University of Washington and a doctorate from the University of California, San Francisco.

John Amory active positions

Companies	Position	Start
University of Washington University of Washington Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01/07/2011

All active positions of John Amory

Former positions of John Amory

Companies	Position	End
CLARUS THERAPEUTICS HOLDINGS, INC.	Director/Board Member	31/10/2022
Clarus Therapeutics, Inc. Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism	Director/Board Member	-

See the detail of John Amory's experience

Training of John Amory

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Amory's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Clarus Therapeutics, Inc. Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism	Health Technology
University of Washington University of Washington Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of California, San Francisco The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Clarus Therapeutics Holdings, Inc. Clarus Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops oral T-replacement therapies	Health Technology

See company connections